Christopher Thang
MS4 | 24-25 Research Fellow @ MGH/Harvard Med
- Role
- Pugh Scholar, Sics and Research Fellow, Department of Dermatology at Massachusetts General Hospital
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Christopher Thang
I am a fourth-year medical student at University of Texas Medical Branch and a prior research fellow in dermatology informatics at Massachusetts General Hospital and Harvard Medical School. My work focuses on oncodermatology and acne, where I design epidemiological analyses to evaluate patient outcomes, medication safety, and associations with potential comorbidities. I have first/co-first authored publications in leading journals, including the Journal of the American Academy of Dermatology (JAAD), JAMA Dermatology, Allergy, and the British Journal of Dermatology (BJD). My work has also been featured in the New York Times, Healio, AAD Derm World Weekly, and Elsevier PracticeUpdate Dermatology. As a future dermatology applicant (#Match2026), I am interested in exploring novel therapeutic modalities, rare dermatologic conditions, and technological advances in clinical practice. Outside of academics, I am passionate about fitness and mentorship. As the founder of Hypergrowth Body Transformation Consulting, I have guided over 500 busy professionals worldwide to achieve lasting weight loss, build lean muscle, and adopt healthy habits. My goal is to inspire others to improve their health through holistic and sustainable lifestyle changes.
Experience
Pugh Scholar, Sics and Research Fellow, Department of Dermatology
Massachusetts General Hospital
Apr 2023 — Present · Boston, MA, US
Mentored by Dr. Yevgeniy (Eugene) Semenov, Director of the Dermatology Clinical Informatics Laboratory at the Massachusetts General Hospital and Harvard Medical School.• Pugh Scholar (MGH Severe Immunotherapy Complications Service)Selected publications:• Thang CJ, Duffy C, Khattab S, Semenov YR. The Current State and Future Prospects for Artificial Intelligence in Dermatology. Dermatologic Clinics. 2025 Jul 22.• Cheng D, Nguyen NT, Thang CJ, Burke OM, LeBoeuf NR, Theodosakis N, Semenov YR. Exposure to intravenous immunoglobulin is associated with increased mortality in patients on immune checkpoint inhibitors: a population-based cohort study. JAAD International. 2025 Aug 6.• Azin M, Farokh P, McGarry A, Leung BW, Roster K, Rashdan H, Rajeh A, Khattab S, Stephens MR, Thang CJ, Fisher DE. Type 2 Immunity Links Eczematous and Lichenoid Eruptions Caused by Immune Checkpoint Inhibitors. Journal of the American Academy of Dermatology. 2025 Aug 8.• Roster K, Rajeh A, Wu F, Wan G, Thang C, Rashdan H, Nguyen N, Semenov YR. Recurrence and survival in early-stage acral lentiginous melanoma: A retrospective analysis. Journal of the American Academy of Dermatology. 2023 Dec 1;89(6):1276-9.Semenov Lab Website: https://semenovlab.org/
Education
University of North Texas
Texas Academy of Mathematics and Science (TAMS), University of North Texas Honors College
2016 — 2018
Harvard Medical School - Massachusetts General Hospital
Research Fellow in Oncodermatology & Clinical Informatics; Pugh Scholar
University of Houston
Honors Biomedical Sciences (HBS) 3/4 Accelerated BS/MD Program, Medicine
2018 — 2021
The University of Texas Medical Branch
Doctor of Medicine (MD), Medicine
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.